Although PSA testing has positively influenced the diagnosis and treatment of prostate cancer, significantly decreasing the prostate cancer-related mortality rate [7,8,9,10,11], it has drawbacks that have negatively affected certain men. This evidence concerns the gene KLK3 and prostate carcinoma.